Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

cold contaminant-free Iobenguane I-131

An I 131 radioiodinated synthetic analogue of the neurotransmitter norepinephrine, manufactured with a proprietary process, with radioisotopic and potential antineoplastic activities. Cold contaminant-free iobenguane I 131 (MIBG) localizes to adrenergic tissue and may be used to image or eradicate tumor cells that accumulate and metabolize norepinephrine. This agent is manufactured using a technology that avoids the production of unwanted "cold contaminants" (i.e., carrier molecules), which may cause undesirable side effects and compete with MIBG for binding on target receptor sites.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:cold contaminant-free I 131-MIBG
cold contaminant-free iobenguane I 131
cold contaminant-free iodine I 131 metaiodobenzylguanidine
ultratrace iodine I 131 metaiodobenzylguanidine
US brand name:Azedra
Abbreviation:Ultratrace MIBG
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search